Perioperative Considerations for Patients on GLP1 Agonists

Oct 23, 2024Advances in anesthesia

Care Guidelines for Surgery Patients Taking GLP-1 Medicines

AI simplified

GLP-1 Therapies on OpenScience ↗PubMed ↗DOI ↗

Abstract

GlP-1 receptor agonists provide reliable weight loss and improved glycemic control in obese and diabetic patients.

These medications may enhance overall metabolic health.
They are associated with improved cardiovascular outcomes in high-risk populations.
Glucagon-like peptide 1 receptors stimulate various tissues, including the pancreas and heart.
The effects of these medications on gastric emptying are particularly relevant for anesthesia professionals.

AI simplified

GlP-1 receptor agonists are a class of medications that are becoming increasingly popular. Large trials have shown that their use provides reliable weight loss in obese patients and improved glycemic control in diabetic patients. Its use also has broader implications for overall metabolic health and has been shown to improve cardiovascular outcomes in high-risk populations. Glucagon-like peptide 1 receptors cause multiple effects in the body through stimulation of receptors expressed in a broad range of tissues including the pancreas, liver, gastrointestinal tract, kidneys, heart, endothelium, muscle, and brain. For the anesthesia professionals the effects of these medications on gastric emptying is important.

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

Perioperative Considerations for Patients on GLP1 Agonists

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the glp-1 therapies brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the glp-1 therapies brief